Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: l-NAME, l-arginine, stable gastric pentadecapeptide BPC 157

NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs

(2016) Antonio Kokot et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

(2016) Ming-Jer Hsieh et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats

(2015) Heba H. Mansour et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro

(2015) Tonglie Huang et al.   Drug Design Development and Therapy

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine

(2015) Mirjana Stupnisek et al.   PLoS One

BPC 157 and Blood Vessels

(2014) Sven Seiwerth et al.   CURRENT PHARMACEUTICAL DESIGN

Stable Gastric Pentadecapeptide BPC 157-NO-system Relation

(2014) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts

(2014) Chung-Hsun Chang et al.   MOLECULES

Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157

(2013) Ivan Barisic et al.   REGULATORY PEPTIDES

Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157

(2012) P. Sikiric et al.   CURRENT MEDICINAL CHEMISTRY

Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy

(2012) Vedran Cesarec et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

(2011) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats

(2011) Spomenko Ilic et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac-induced gastrointestinal, liver, and encephalopathy lesions

(2011) Spomenko Ilic et al.   LIFE SCIENCES

Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin

(2011) Mirjana Stupnisek et al.   THROMBOSIS RESEARCH

Revised Roberts Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator

(2010) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

(2010) Chung-Hsun Chang et al.   JOURNAL OF APPLIED PHYSIOLOGY

Acacia Senegal Gum Exudate Offers Protection Against Cyclophosphamide-Induced Urinary Bladder Cytotoxicity

(2010) Abdulaziz A. Al-Yahya et al.   Oxidative Medicine and Cellular Longevity

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

(2008) Satori A Marchitti et al.   Expert Opinion on Drug Metabolism & Toxicology